| Digital image analysis outperforms manual biomarker assessment in breast cancer G Stålhammar, NF Martinez, M Lippert, NP Tobin, I Mølholm, L Kis, ... Modern Pathology 29 (4), 318-329, 2016 | 199 | 2016 |
| CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment SY Neo, Y Yang, J Record, R Ma, X Chen, Z Chen, NP Tobin, E Blake, ... The Journal of clinical investigation 130 (3), 1185-1198, 2020 | 175 | 2020 |
| Cyclin D1, Id1 and EMT in breast cancer NP Tobin, AH Sims, KL Lundgren, S Lehn, G Landberg BMC cancer 11, 1-14, 2011 | 135 | 2011 |
| Use of molecular tools to identify patients with indolent breast cancers with ultralow risk over 2 decades LJ Esserman, C Yau, CK Thompson, LJ van't Veer, AD Borowsky, ... JAMA oncology 3 (11), 1503-1510, 2017 | 129 | 2017 |
| Impact of epithelial–stromal interactions on peritumoral fibroblasts in ductal carcinoma in situ C Strell, J Paulsson, SB Jin, NP Tobin, A Mezheyeuski, P Roswall, ... JNCI: Journal of the National Cancer Institute 111 (9), 983-995, 2019 | 127 | 2019 |
| Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival NP Tobin, JC Harrell, J Lövrot, SE Brage, MF Stolt, L Carlsson, Z Einbeigi, ... Annals of oncology 26 (1), 81-88, 2015 | 100 | 2015 |
| STAT3 activity promotes programmed-death ligand 1 expression and suppresses immune responses in breast cancer I Zerdes, M Wallerius, EG Sifakis, T Wallmann, S Betts, M Bartish, ... Cancers 11 (10), 1479, 2019 | 81 | 2019 |
| Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features S Lehn, NP Tobin, P Berglund, K Nilsson, AH Sims, K Jirström, ... The American journal of pathology 177 (6), 2886-2897, 2010 | 81 | 2010 |
| Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling O Frings, M Augsten, NP Tobin, J Carlson, J Paulsson, C Pena, E Olsson, ... The American journal of pathology 182 (6), 2037-2047, 2013 | 75 | 2013 |
| Role of tumor pericytes in the recruitment of myeloid-derived suppressor cells JW Hong, NP Tobin, H Rundqvist, T Li, M Lavergne, Y García-Ibáñez, ... Journal of the National Cancer Institute 107 (10), djv209, 2015 | 71 | 2015 |
| Astrocytes enhance glioblastoma growth A Mega, M Hartmark Nilsen, LW Leiss, NP Tobin, H Miletic, L Sleire, ... Glia 68 (2), 316-327, 2020 | 64 | 2020 |
| The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer NP Tobin, T Foukakis, L De Petris, J Bergh Journal of Internal Medicine 278 (6), 545-570, 2015 | 64 | 2015 |
| The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours A Lundberg, LS Lindström, J Li, JC Harrell, E Darai-Ramqvist, EG Sifakis, ... Breast Cancer Research 21, 1-10, 2019 | 62 | 2019 |
| Guidance molecule SEMA3A restricts tumor growth by differentially regulating the proliferation of tumor-associated macrophages M Wallerius, T Wallmann, M Bartish, J Östling, A Mezheyeuski, NP Tobin, ... Cancer research 76 (11), 3166-3178, 2016 | 60 | 2016 |
| High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer J Paulsson, L Rydén, C Strell, O Frings, NP Tobin, T Fornander, J Bergh, ... The Journal of Pathology: Clinical Research 3 (1), 38-43, 2017 | 53 | 2017 |
| Gene expression signatures and immunohistochemical subtypes add prognostic value to each other in breast cancer cohorts A Lundberg, LS Lindström, JC Harrell, C Falato, JW Carlson, PK Wright, ... Clinical Cancer Research 23 (24), 7512-7520, 2017 | 50 | 2017 |
| Assessment of long-term distant recurrence-free survival associated with tamoxifen therapy in postmenopausal patients with luminal A or luminal B breast cancer YY Nancy, A Iftimi, C Yau, NP Tobin, L van’t Veer, KA Hoadley, CC Benz, ... JAMA oncology 5 (9), 1304-1309, 2019 | 48 | 2019 |
| Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response S Lehn, NP Tobin, AH Sims, O Stål, K Jirström, H Axelson, G Landberg BMC cancer 14, 1-16, 2014 | 47 | 2014 |
| Immune gene expression and response to chemotherapy in advanced breast cancer T Foukakis, J Lövrot, A Matikas, I Zerdes, J Lorent, N Tobin, C Suzuki, ... British journal of cancer 118 (4), 480-488, 2018 | 46 | 2018 |
| Separation of breast cancer and organ microenvironment transcriptomes in metastases MA Alzubi, TH Turner, AL Olex, SS Sohal, NP Tobin, SG Recio, J Bergh, ... Breast Cancer Research 21, 1-15, 2019 | 45 | 2019 |
Johan HartmanDept of Oncology-Pathology, Karolinska InstitutetVerified email at ki.se
